Intellia Therapeutics Stock News & Updates

[WKN: A2AG6H | Symbol: NTLA]

Intellia Therapeutics: Board of Directors Takes Advantage of Stock Plunge for a $1.4 Million Stock Purchase

Intellia Therapeutics (NTLA) positions itself in the field of CRISPR/Cas9 technology to directly cure...

Intellia Therapeutics (NTLA) - CRISPR Specialist Impresses with Strong Pipeline!

Business Driver: Intellia Therapeutics (NTLA) specializes in the treatment of genetic diseases, primarily...

Analysts' Top 5 Price Targets of October 6, 2025

Redcare Pharmacy [NL0012044747] Jefferies confirms Buy rating with a price target of €150 (82% price...

Intellia Therapeutics: Wells Fargo Sees 173% Growth Potential!

Intellia Therapeutics (NTLA) has made it to the list of the analysts' top 10 price targets. The biotech...

Analysts' Top 5 Price Targets of September 19, 2025

Befesa [LU1704650164] UBS starts coverage with Buy and a price target of €44 (58% upside potential)...

Stocks in Action USA: Meta, Jabil, Intellia Therapeutics

Meta (META): WhatsApp becomes an advertising platform – the exploitation of a new revenue source begins!...

Analysts' Top 5 Price Targets of March 5, 2025

AxoGen [US05463X1063]: JMP Securities reaffirms Buy rating and raises the price target from $20 to $26...

  • 1